Literature DB >> 28151809

Liver transplantation around the world.

James F Trotter1.   

Abstract

PURPOSE OF REVIEW: In the past few years, there have been important changes in the development of liver transplantation around the world. In particular, several emerging countries have rapidly developed transplant programs. There have also been important changes in liver allocation, utilization of donors by cardiac death, and living donors. A review of the practices in different countries around the world will help provide the reader with a better appreciation of their own program as well as the recognition of potential areas of improvement based on the experience of their colleagues. RECENT
FINDINGS: A recent series of articles has been published in the journal Liver Transplantation summarizing the practice of liver transplantation from representative countries around the world.
SUMMARY: The volume of liver transplant varies widely by country and there has been an important growth in volume in emerging countries. Most liver transplant candidates are prioritized for surgery by the Model for Endstage Liver Disease score and with the exception of Germany and the USA most patients are transplanted at Model for Endstage Liver Disease score from 18 to 20. Hepatitis C is the most common indication for liver transplant with the notable exception of several European countries. Innovative strategies to incentivize donation have been developed in several countries.

Entities:  

Mesh:

Year:  2017        PMID: 28151809     DOI: 10.1097/MOT.0000000000000392

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  11 in total

1.  Nonalcoholic Steatohepatitis: A Rapidly Increasing Indication for Liver Transplantation in India.

Authors:  Dinesh Jothimani; Silas Danielraj; Gomathy Narasimhan; Ilankumaran Kaliamoorthy; Akila Rajakumar; Kumar Palaniappan; Swetha Palanichamy; Ashwin Rammohan; Hemalatha Ramachandran; Rajesh Rajalingam; Mohamed Rela
Journal:  J Clin Exp Hepatol       Date:  2021-09-25

2.  Role of proenkephalin in the diagnosis of severe and subclinical acute kidney injury during the perioperative period of liver transplantation.

Authors:  Camila Lima; Daniella Lacerda Gorab; Carol Ribeiro Fernandes; Etienne Macedo
Journal:  Pract Lab Med       Date:  2022-05-06

3.  Sex Disparities in Outcome of Patients with Alcohol-Related Liver Cirrhosis within the Eurotransplant Network-A Competing Risk Analysis.

Authors:  Stephan Listabarth; Daniel König; Gabriela Berlakovich; Petra Munda; Peter Ferenci; Dagmar Kollmann; Georg Gyöeri; Thomas Waldhoer; Magdalena Groemer; Arjan van Enckevort; Benjamin Vyssoki
Journal:  J Clin Med       Date:  2022-06-24       Impact factor: 4.964

4.  Salvage living donor liver transplantation for posthepatectomy recurrence: a higher incidence of recurrence but promising strategy for long-term survival.

Authors:  Kun-Ming Chan; Chih-Hsien Cheng; Tsung-Han Wu; Chen-Fang Lee; Ting-Jung Wu; Hong-Shiue Chou; Wei-Chen Lee
Journal:  Cancer Manag Res       Date:  2019-08-02       Impact factor: 3.989

5.  Risk Factors for Sepsis Based on Sepsis-3 Criteria after Orthotopic Liver Transplantation.

Authors:  Yanling Wang; Yu Gu; Fei Huang; Dezhao Liu; Zheng Zhang; Niman Zhou; Jiani Liang; Changyin Lu; Dongdong Yuan; Ziqing Hei
Journal:  Mediators Inflamm       Date:  2018-06-20       Impact factor: 4.711

6.  Secondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitis.

Authors:  Martha M Kirstein; Thorsten Book; Michael P Manns; Thomas von Hahn; Torsten Voigtländer
Journal:  United European Gastroenterol J       Date:  2020-05-04       Impact factor: 4.623

7.  Global impact of the first wave of COVID-19 on liver transplant centers: A multi-society survey (EASL-ESOT/ELITA-ILTS).

Authors:  Francesco Paolo Russo; Manhal Izzy; Ashwin Rammohan; Varvara A Kirchner; Tommaso Di Maira; Luca Saverio Belli; Thomas Berg; Marina Carmen Berenguer; Wojciech Grzegorz Polak
Journal:  J Hepatol       Date:  2021-10-13       Impact factor: 25.083

8.  Role of PNPLA3 in the Assessment and Monitoring of Hepatic Steatosis and Fibrosis in Patients with Chronic Hepatitis C Infection Who Achieved a Sustained Virologic Response.

Authors:  Oana Irina Gavril; Lidia Iuliana Arhire; Otilia Gavrilescu; Mihaela Dranga; Oana Barboi; Radu Sebastian Gavril; Roxana Popescu; Cristina Cijevschi Prelipcean; Anca-Victorita Trifan; Catalina Mihai
Journal:  Medicina (Kaunas)       Date:  2021-10-24       Impact factor: 2.430

Review 9.  Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment.

Authors:  Ruyin Chen; Qiong Li; Shuaishuai Xu; Chanqi Ye; Tian Tian; Qi Jiang; Jianzhen Shan; Jian Ruan
Journal:  Cancer Cell Int       Date:  2022-02-11       Impact factor: 5.722

10.  Model for establishing a new liver transplantation center through mentorship from a university with transplantation expertise.

Authors:  Rafael Soares Pinheiro; Wellington Andraus; Fernando Gomes Romeiro; Rodrigo Bronze de Martino; Liliana Ducatti; Rubens Macedo Arantes; Leonardo Pelafsky; Claudia Nishida Hasimoto; Fabio da Silva Yamashiro; Lucas Souto Nacif; Luciana Bertocco de Paiva Haddad; Vinicius Rocha Santos; Daniel Reis Waisberg; Matheus Fachini Vane; Joel Avancini Rocha-Filho; Walmar Kerche de Oliveira; Luiz Augusto Carneiro-D'Albuquerque
Journal:  PLoS One       Date:  2022-03-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.